However, it has also been reported that GLP1-RAs may promote pathways with a potential role in the development of colorectal cancer [173], which supports the need for further studies in order to reach a definitive conclusion on the role of these antidiabetic agents on colon cancer. The gene discussed is GLP1R; the disease is colonic neoplasm.